Skip to main content
Toggle navigation
Login
Search
Home
Favorite
Like
Facebook
Tweet
Clinical Applications
SAFETY, TOLERABILITY, AND EFFICACY OF TRANSPLANTED AUTOLOGOUS IPSC-DERIVED DOPAMINERGIC PRECURSORS IN MODERATE TO ADVANCED PARKINSON’S DISEASE
Wednesday, June 11, 2025
9:15 AM – 9:35 AM
HK Time
Location: Theater 1, L1
Presenting Author(s)
Andres Bratt-Leal, PhD
Aspen Neuroscience Inc., United States